1 / 1

Supplementary Figure 4

Supplementary Figure 4. PELP1 TG +Par. PELP1 TG. WT. A. DiK9me2. B. C. PELP1 TG. PELP1 TG + Par. PELP1 TG. PELP1 TG + Par. Cyclin D1. Ser991 PELP1.

carly-harvey
Download Presentation

Supplementary Figure 4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 4 PELP1 TG +Par PELP1 TG WT A DiK9me2 B C PELP1 TG PELP1 TG + Par PELP1 TG PELP1 TG + Par Cyclin D1 Ser991PELP1 Figure S4.A, Representative IHC images showing the status of diK9me2 in the mammary glands of 6-month-old control and MMTV-rtTA-TetO-PELP1 bitransgenic mice treated with PBS or pargyline. B,C, Representative IHC images showing the status of cyclin D1 (B) and phos-PELP1 (C) in the mammary glands of 6-month-old MMTV-rtTA-TetO-PELP1 bitransgenic mice treated with PBS or pargyline.

More Related